Chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients aged 45-75 years with mild to moderate COPD in stable stage; 2. meet the diagnostic criteria: FEV1/FVC =50% after using bronchodilator, with a history of respiratory symptoms and / or risk factors exposure; 3. one month or more after acute attack treatment; 4. did not participate in other traditional exercise before being selected; 5. voluntarily participated in this study with informed consent and signed informed consent form; 6. those with clear consciousness and stable cardiopulmonary function.
Exclusion criteria
Exclusion criteria: 1. patients with chronic cough and wheezing caused by tuberculosis, fungus, tumor, irritant gas, allergy and other factors; and patients diagnosed as bronchial asthma, bronchiectasis, lung cancer, congestive heart failure, bronchiolitis obliterans, diffuse panbronchiolitis, bronchial keratosis, etc.; 2. patients with cardiovascular, urinary, digestive, blood, endocrine and other serious primary diseases and inability to cooperate with spirit, intelligence or even thinking; 3. pregnant or lactating women; 4. patients who are participating in other clinical trials; 5. researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Medical Research Council Dyspnea Scale;Six-minute walk test;BODE index;Serum interleukin-8;COPD assessment test (CAT);Serum C-reactive protein;Six-minute walk test;Exhaled nitric oxide concentration; | — |
Countries
China
Contacts
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine